- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia in United Kingdom
Total 4603 results
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
King's College LondonKing's College Hospital NHS TrustUnknownAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited Kingdom
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
OnxeoCompletedB-cell Chronic Lymphocytic LeukemiaUnited Kingdom
-
Janssen Research & Development, LLCRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute LeukemiasUnited States, United Kingdom, France, Spain, Australia
-
Medical Research CouncilUnknownLeukemiaUnited Kingdom
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
Medical Research CouncilUnknownLeukemia | NeutropeniaUnited Kingdom
-
The Royal Bournemouth HospitalCLL Topics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited Kingdom
-
Leeds Cancer Centre at St. James's University HospitalCompleted
-
Medical Research CouncilUnknownLeukemiaUnited Kingdom
-
University of SurreyAmerican Society of HematologyRecruitingFrailty | Chronic Lymphocytic Leukemia | Muscle Function | Immune Function | Lipid Cell; TumorUnited Kingdom
-
Medical Research CouncilCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicUnited Kingdom
-
SanofiTerminatedAcute Myeloid LeukaemiaUnited States
-
Imperial College Healthcare NHS TrustActive, not recruitingFatigue | Sleep Disturbance | Chronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic PhaseUnited Kingdom
-
University of LeedsCompleted
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
University of LiverpoolGlaxoSmithKline; Chugai Pharma USA; Napp Pharmaceuticals LimitedUnknownChronic Lymphocytic LeukaemiaUnited Kingdom
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited Kingdom
-
Gilead SciencesCompletedInvasive Fungal DiseaseUnited Kingdom
-
NovalGen Ltd.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Non-small Cell Lung Cancer (NSCLC) | Small Lymphocytic Lymphoma | Malignant Melanoma | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
PfizerCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited Kingdom
-
OnxeoCompletedAcute Myeloid LeukemiaUnited Kingdom, Germany, France
-
University College, LondonActive, not recruitingLeukemia | Mucositis | Oral ComplicationsUnited Kingdom
-
Lynn McMahonMedical Research Council; CRUK Trials unit GlasgowUnknown
-
King's College Hospital NHS TrustUnknownMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited Kingdom
-
University of BathUniversity of Southampton; Royal United Hospitals Bath NHS Foundation Trust; Great...CompletedChronic Lymphocytic Leukemia | Minimal Residual DiseaseUnited Kingdom
-
King's College LondonCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited Kingdom
-
University of HullCompletedAcute LeukemiaUnited Kingdom
-
Riverside Haematology GroupUnknownMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
SanofiTerminated
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
University College, LondonDeutsche Krebshilfe e.V., Bonn (Germany); European Union; The Leukemia and Lymphoma... and other collaboratorsTerminatedAcute Lymphoblastic LeukemiaUnited Kingdom, Germany
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astex Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory LeukemiasUnited States
-
Akinion Pharmaceuticals ABTerminatedAcute Myeloid LeukemiaSweden, Poland, Czech Republic, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute LeukemiasHungary, Belgium, Germany, Austria, Netherlands, Australia, Canada, Spain, Norway, United Kingdom, United States
-
King's College Hospital NHS TrustTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited Kingdom
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
Great Ormond Street Hospital for Children NHS Foundation...Recruiting
-
King's College Hospital NHS TrustCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Bone Marrow Transplantation | Aplastic AnemiaUnited Kingdom
-
Hoffmann-La RocheCompletedA Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.Lymphocytic Leukemia, ChronicUnited Kingdom
-
Inmune Bio, Inc.TerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | AML | MDS-EBUnited Kingdom, Greece
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicAustralia, United States, New Zealand
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
Cardiff UniversityCancer Research UKUnknownMyelodysplastic Syndrome | Acute Myeloid LeukaemiaDenmark, United Kingdom
-
Novartis PharmaceuticalsCompletedLeukaemiaBelgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
-
Novartis PharmaceuticalsCompletedLeukaemia, Lymphocytic, ChronicIndia, United Kingdom, Netherlands, Canada, Germany, Greece, Italy, Poland, Russian Federation, Spain, Taiwan, Thailand, United States, Brazil, Bulgaria, Mexico, Romania, Ukraine